155
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Cyclophotocoagulation versus Ahmed Glaucoma Implant in Neovascular Glaucoma with Poor Vision at Presentation

, , , &
Pages 163-171 | Received 12 Jun 2023, Accepted 19 Dec 2023, Published online: 16 Jan 2024

References

  • Rodrigues GB, Abe RY, Zangalli C, et al. Neovascular glaucoma: a review. Int J Retina Vitreous. 2016;2:26. doi:10.1186/s40942-016-0051x
  • Shazly TA, Latina MA. Neovascular glaucoma: etiology, diagnosis and prognosis. Semin Ophthalmol. 2009;24(2):113–121. doi:10.1080/08820530902800801
  • Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res. 2007;26(5):470–485. doi:10.1016/j.preteyeres.2007.06.001
  • Wang JW, Zhou MW, Zhang X, et al. Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma. Clin Exp Ophthalmol. 2015;43(5):415–421. doi:10.1111/ceo.12477
  • Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331(22):1480–1487. doi:10.1056/NEJM199412013312203
  • Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol. 2006;142(6):1054–1056. doi:10.1016/j.ajo.2006.06.066
  • Sivak-Callcott JA, O’Day DM, Gass JD, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001;108(10):1767–1776. doi:10.1016/s0161-6420(01)00775-8
  • Yalvac IS, Eksioglu U, Satana B, Duman S. Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma. Eye. 2007;21(1):65–70. doi:10.1038/sj.eye.6702125
  • Yildirim N, Yalvac IS, Sahin A, Ozer A, Bozca T. A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma: a long‑term follow‑up. J Glaucoma. 2009;18:192–196. doi:10.1097/IJG.0b013e31817d235c
  • Iliev ME, Gerber S. Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol. 2007;91(12):1631–1635. doi:10.1136/bjo.2007.116533
  • Ramli N, Htoon HM, Ho CL, Aung T, Perera S. Risk factors for hypotony after transscleral diode cyclophotocoagulation. J Glaucoma. 2012;21(3):169–173. doi:10.1097/IJG.0b013e318207091a
  • Lima FE, Magacho L, Carvalho DM, et al. A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. J Glaucoma. 2004;13:233–237. doi:10.1097/00061198-200406000-00011
  • Chalam KV, Gandham S, Gupta S, Tripathi BJ, Tripathi RC. Pars plana modifid Baerveldt implant versus neodymium: YAG cyclophotocoagulation in the management of neovascular glaucoma. Ophthalm Surg Lasers. 2002;33:383–393. doi:10.3928/1542-8877-20020901-08
  • Schwartz KS, Lee RK, Gedde SJ. Glaucoma drainage implants: a critical comparison of types. Curr Opin Ophthalmol. 2006;17:181–189. doi:10.1097/01.icu.0000193080.55240.7e
  • Mistlberger A, Liebmann JM, Tschiderer H, Ritch R, Ruckhofer J, Grabner G. Diode laser transscleral cyclophotocoagulation for refractoryglaucoma. J Glaucoma. 2001;10:288–293. doi:10.1097/00061198-200108000-00008